These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
923 related articles for article (PubMed ID: 9200008)
1. Relationship of bone turnover to bone density and fractures. Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [TBL] [Abstract][Full Text] [Related]
2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [TBL] [Abstract][Full Text] [Related]
3. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
4. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854 [TBL] [Abstract][Full Text] [Related]
5. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636 [TBL] [Abstract][Full Text] [Related]
6. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover. Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890 [TBL] [Abstract][Full Text] [Related]
7. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis]. Garnero P; Delmas PD Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740 [TBL] [Abstract][Full Text] [Related]
8. Biochemical markers as predictors of rates of bone loss after menopause. Rogers A; Hannon RA; Eastell R J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690 [TBL] [Abstract][Full Text] [Related]
9. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. Akesson K; Ljunghall S; Jonsson B; Sernbo I; Johnell O; Gärdsell P; Obrant KJ J Bone Miner Res; 1995 Nov; 10(11):1823-9. PubMed ID: 8592961 [TBL] [Abstract][Full Text] [Related]
10. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515 [TBL] [Abstract][Full Text] [Related]
11. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF; Geyikli I; Yazgan P; Celik A Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [TBL] [Abstract][Full Text] [Related]
12. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. Garnero P; Sornay-Rendu E; Duboeuf F; Delmas PD J Bone Miner Res; 1999 Sep; 14(9):1614-21. PubMed ID: 10469291 [TBL] [Abstract][Full Text] [Related]
13. Cross-sectional evaluation of bone metabolism in men. Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833 [TBL] [Abstract][Full Text] [Related]
14. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288 [TBL] [Abstract][Full Text] [Related]
15. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women. Cosman F; Nieves J; Woelfert L; Shen V; Lindsay R J Bone Miner Res; 1998 Jun; 13(6):1051-5. PubMed ID: 9626638 [TBL] [Abstract][Full Text] [Related]
16. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. Bauer DC; Black DM; Garnero P; Hochberg M; Ott S; Orloff J; Thompson DE; Ewing SK; Delmas PD; J Bone Miner Res; 2004 Aug; 19(8):1250-8. PubMed ID: 15231011 [TBL] [Abstract][Full Text] [Related]
17. Monitoring alendronate therapy for osteoporosis. Braga de Castro Machado A; Hannon R; Eastell R J Bone Miner Res; 1999 Apr; 14(4):602-8. PubMed ID: 10234582 [TBL] [Abstract][Full Text] [Related]
18. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis. Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460 [TBL] [Abstract][Full Text] [Related]
19. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013 [TBL] [Abstract][Full Text] [Related]
20. Rapid bone loss is associated with increased levels of biochemical markers. Ross PD; Knowlton W J Bone Miner Res; 1998 Feb; 13(2):297-302. PubMed ID: 9495524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]